Levin B, Lieberman DA, McFarland B et al.. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130–160.
- Search Google Scholar
- Export Citation
. Levin B Lieberman DA McFarland B Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58: 130– 160.
Rex DK, Johnson DA, Anderson JC et al.. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739–750.
USPSTF. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627–637.
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212–236.
Meester RG, Doubeni CA, Lansdorp-Vogelaar I et al.. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol 2015;25:208–213.e1.
Meester RG, Doubeni CA, Zauber AG et al.. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018 [published online ahead of print]. Cancer, doi: 10.1002/cncr.29336.
Nishihara R, Wu K, Lochhead P et al.. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369:1095–1105.
Atkin WS, Edwards R, Kralj-Hans I et al.. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624–1633.
Schoen RE, Pinsky PF, Weissfeld JL et al.. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345–2357.
Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846.
Segnan N, Armaroli P, Bonelli L et al.. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial—SCORE. J Natl Cancer Inst 2011;103:1310–1322.
Holme O, Loberg M, Kalager M et al.. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 2014;312:606–615.
Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467.
Elmunzer BJ, Hayward RA, Schoenfeld PS et al.. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2012;9:e1001352.
Holme O, Bretthauer M, Fretheim A et al.. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013;9:CD009259.
Shroff J, Thosani N, Batra S et al.. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis. World J Gastroenterol 2014;20:18466–18476.
Brenner H, Chang-Claude J, Seiler CM et al.. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:22–30.
Brenner H, Chang-Claude J, Jansen L et al.. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2014;146:709–717.
Citarda F, Tomaselli G, Capocaccia R et al.. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812–815.
Jacob BJ, Moineddin R, Sutradhar R et al.. Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc 2012;76:355–364.e1.
Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770–775; quiz 711.
Winawer SJ, Zauber AG, Ho MN et al.. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977–1981.
Manser CN, Bachmann LM, Brunner J et al.. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc 2012;76:110–117.
Morois S, Cottet V, Racine A et al.. Colonoscopy reduced distal colorectal cancer risk and excess cancer risk associated with family history. Cancer Causes Control 2014;25:1329–1336.
Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904–910.
Rabeneck L, Paszat LF, Saskin R, Stukel TA. Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol 2010;105:1627–1632.
Amri R, Bordeianou LG, Sylla P, Berger DL. Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg 2013;148:747–754.
Johnson DA, Barkun AN, Cohen LB et al.. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroenterology 2014;147:903–924.
Enestvedt BK, Tofani C, Laine LA et al.. 4-Liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol 2012;10:1225–1231.
Gurudu SR, Ramirez FC, Harrison ME et al.. Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy. Gastrointest Endosc 2012;76:603–608.e1.
Kilgore TW, Abdinoor AA, Szary NM et al.. Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc 2011;73:1240–1245.
Longcroft-Wheaton G, Bhandari P. Same-day bowel cleansing regimen is superior to a split-dose regimen over 2 days for afternoon colonoscopy: results from a large prospective series. J Clin Gastroenterol 2012;46:57–61.
Matro R, Shnitser A, Spodik M et al.. Efficacy of morning-only compared with split-dose polyethylene glycol electrolyte solution for afternoon colonoscopy: a randomized controlled single-blind study. Am J Gastroenterol 2010;105:1954–1961.
Varughese S, Kumar AR, George A, Castro FJ. Morning-only one-gallon polyethylene glycol improves bowel cleansing for afternoon colonoscopies: a randomized endoscopist-blinded prospective study. Am J Gastroenterol 2010;105:2368–2374.
Kriza C, Emmert M, Wahlster P et al.. An international review of the main cost-effectiveness drivers of virtual colonography versus conventional colonoscopy for colorectal cancer screening: is the tide changing due to adherence? Eur J Radiol 2013;82:e629–636.
Kim DH, Pickhardt PJ, Taylor AJ, Menias CO. Imaging evaluation of complications at optical colonoscopy. Curr Probl Diagn Radiol 2008;37:165–177.
Whitlock EP, Lin JS, Liles E et al.. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638–658.
Johnson CD, Chen MH, Toledano AY et al.. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207–1217.
Halligan S, Altman DG, Taylor SA et al.. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005;237:893–904.
Togashi K, Utano K, Kijima S et al.. Laterally spreading tumors: limitations of computed tomography colonography. World J Gastroenterol 2014;20:17552–17557.
Hardcastle JD, Chamberlain JO, Robinson MH et al.. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–1477.
Kronborg O, Fenger C, Olsen J et al.. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–1471.
Mandel JS, Bond JH, Church TR et al.. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365–1371.
Ahlquist DA, Sargent DJ, Loprinzi CL et al.. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441–450, W481.
Ahlquist DA, Zou H, Domanico M et al.. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012;142:248–256; quiz e225–246.
Imperiale TF, Ransohoff DF, Itzkowitz SH et al.. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370:1287–1297.
Taylor DP, Burt RW, Williams MS et al.. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 2010;138:877–885.
Taylor DP, Stoddard GJ, Burt RW et al.. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med 2011;13:385–391.
Samadder NJ, Curtin K, Tuohy TM et al.. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology 2014;147:814–821.e5; quiz e815–816.
Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med 2012;156:703–709.
Tuohy TM, Rowe KG, Mineau GP et al.. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer 2014;120:35–42.